Skip to main content
    N

    Neurogene Inc (NGNE)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $23.30
    -0.63 (-2.63%)

    Market Cap: $495.37M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Neurogene Inc (NGNE) Earnings: Report Dates and Results

    Updated Nov 9, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Neurogene (NGNE) is expected to report earnings on Mar 22, 2027. In the quarter ended Sep 30, 2026, Neurogene reported EPS of -$1.05, above the -$1.49 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    58%(22/38)
    Avg Surprise
    -1.67%
    Streak
    1 Q

    Upcoming Estimates

    Reports Mar 22, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$1.38
    Range-$1.61 - -$1.04
    12 analysts
    Revenue Consensus
    N/A
    RangeN/A
    8 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$1.37
    Range-$1.73 - -$1.18
    3 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$1.21-13.0%
    60d ago-$1.21-13.0%
    30d ago-$1.38+1.2%
    7d ago-$1.38+1.2%
    Current-$1.37
    Revenue Consensus
    N/A
    RangeN/A
    2 analysts

    Next Report

    NGNE has an expected report date of Mar 22, 2027.

    Earnings History

    Of the 38 quarters below that had an estimate, NGNE beat 22, missed 15 and matched 1. The widest gap in the table came in the quarter ended Sep 30, 2018, when EPS landed 204.76% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$1.05-$1.49-$1.59 - -$1.36+29.53%BeatN/A53 up, 3 downNov 9, 2026
    Jun 30, 2026-$1.53-$1.40-$1.44 - -$1.30-9.29%MissN/A21 up, 0 downAug 11, 2026
    Mar 31, 2026-$1.39-$1.27-$1.68 - -$1.00-9.05%MissN/A63 up, 1 downMay 12, 2026
    Dec 31, 2025-$1.13-$1.24-$1.64 - -$1.01+8.87%BeatN/A40 up, 0 downMar 24, 2026
    Sep 30, 2025-$0.99-$1.09-$1.09 - -$1.09+9.17%BeatN/A10 up, 0 downNov 13, 2025
    Jun 30, 2025-$1.05-$1.16N/A+9.48%BeatN/A10 up, 0 downAug 11, 2025
    Mar 31, 2025-$1.08-$1.12N/A+3.57%BeatN/A10 up, 0 downMay 9, 2025
    Dec 31, 2024-$0.99-$1.13-$1.31 - -$1.03+12.39%BeatN/A61 up, 1 downMar 24, 2025
    Sep 30, 2024-$1.19-$1.22-$1.34 - -$1.15+2.46%BeatN/A60 up, 0 downNov 18, 2024
    Jun 30, 2024-$1.09-$1.03N/A-5.83%MissN/AN/AN/AAug 9, 2024
    Mar 31, 2024-$1.00-$0.95N/A-5.26%MissN/AN/AN/AMay 10, 2024
    Dec 31, 2023-$1.51-$1.17N/A-29.06%MissN/AN/AN/AMar 26, 2024
    Sep 30, 2023-$0.41-$0.03N/AN/AN/AN/AN/A0 up, 0 downNov 14, 2023
    Jun 30, 2023-$0.04-$0.04N/A0.00%In lineN/AN/A0 up, 0 downAug 10, 2023
    Mar 31, 2023-$0.26-$0.22N/A-18.18%MissN/AN/AN/AMay 10, 2023
    Dec 31, 2022-$0.24-$0.19N/A-26.32%MissN/AN/AN/AMar 29, 2023
    Sep 30, 2022-$0.24-$0.30N/A+21.13%BeatN/AN/AN/ADec 29, 2022
    Jun 30, 2022-$0.28-$0.30N/A+6.67%BeatN/AN/AN/AAug 9, 2022
    Mar 31, 2022-$0.28-$0.30N/A+6.04%BeatN/AN/AN/AJun 28, 2022
    Dec 31, 2021-$0.28-$0.30N/A+5.31%BeatN/AN/AN/AMar 30, 2022
    Sep 30, 2021-$0.28-$0.28N/A-0.61%MissN/AN/AN/ADec 29, 2021
    Jun 30, 2021-$0.27-$0.26N/A-3.05%MissN/AN/AN/ASep 28, 2021
    Mar 31, 2021-$0.27-$0.23N/A-18.42%MissN/AN/AN/AJun 28, 2021
    Dec 31, 2020-$0.22-$0.24N/A+9.95%BeatN/AN/AN/AMar 30, 2021
    Sep 30, 2020-$0.04-$0.04N/A+9.09%BeatN/AN/AN/ANov 9, 2020
    Jun 30, 2020-$0.20-$0.21N/A+4.76%BeatN/AN/AN/AAug 12, 2020
    Mar 31, 2020-$0.18-$0.23N/A+21.74%BeatN/AN/AN/AJun 29, 2020
    Dec 31, 2019-$0.23-$0.28N/A+17.86%BeatN/AN/AN/AMar 30, 2020
    Sep 30, 2019-$2.26-$0.04N/AN/AN/AN/AN/AN/ADec 29, 2019
    Jun 30, 2019-$0.09-$0.05N/A-80.00%Miss-175.0%N/AN/AAug 7, 2019
    Mar 31, 2019-$0.09-$0.23N/A+60.87%BeatN/AN/AN/AMay 6, 2019
    Dec 31, 2018-$0.21-$0.16N/A-32.91%MissN/AN/AN/AMar 30, 2019
    Sep 30, 2018-$0.64-$0.21N/A-204.76%MissN/AN/AN/ANov 7, 2018
    Jun 30, 2018$0.12-$0.59N/A+120.34%BeatN/AN/AN/AAug 8, 2018
    Mar 31, 2018-$0.62-$0.66N/A+6.06%BeatN/AN/AN/AJun 29, 2018
    Dec 31, 2017-$0.69-$0.57N/A-21.05%MissN/AN/AN/AMar 30, 2018
    Sep 30, 2017-$0.50-$0.59N/A+15.25%BeatN/AN/AN/ANov 8, 2017
    Jun 30, 2017-$0.59-$0.51N/A-15.69%MissN/AN/AN/AAug 8, 2017
    Mar 31, 2017-$0.36-$0.51N/A+29.41%BeatN/AN/AN/AJun 29, 2017
    Dec 31, 2016-$0.48-$0.51N/A+5.88%BeatN/AN/AN/AMar 30, 2017
    Last 40 quarters

    Estimates made before a stock split are shown on the same share basis as the reported EPS.

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$4.25, after -$4.27 the year before. It was -$2.20 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$4.25N/A
    Dec 31, 2024-$4.27N/A
    Dec 31, 2023-$2.22N/A
    Dec 31, 2022-$1.04N/A
    Dec 31, 2021-$1.10N/A
    Dec 31, 2020-$0.64N/A
    Dec 31, 2019-$2.67N/A
    Dec 31, 2018-$1.35N/A
    Dec 31, 2017-$2.14N/A
    Dec 31, 2016-$2.20N/A

    Frequently Asked Questions About NGNE

    When is Neurogene's next earnings date?

    Neurogene's next earnings report is expected for Mar 22, 2027.

    Did NGNE beat earnings estimates last quarter?

    Yes. Neurogene reported EPS of -$1.05 for the quarter ended Sep 30, 2026, above the -$1.49 estimate, a 29.53% surprise.

    What EPS do analysts expect from NGNE next quarter?

    The consensus EPS estimate for Neurogene for the quarter ending Dec 31, 2026 is -$1.38 from 12 analysts, with estimates from -$1.61 to -$1.04.

    How often does NGNE beat earnings estimates?

    Neurogene beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +6.84%.